International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam <p>International Journal of Advances in Medicine (IJAM) is an open access, international, peer-reviewed journal that publishes medical news, original clinical research of interest to physicians in medicine, and reviews on all aspects of clinical medicine. The journal's full text is available online at https://www.ijmedicine.com. The journal allows free access to its contents. International Journal of Advances in Medicine is dedicated to bringing physicians the best research and key information. The journal has a broad coverage of relevant topics in the various disciplines of medicine. International Journal of Advances in Medicine (IJAM) is one of the fastest communication journals and articles are published online within short time after acceptance of manuscripts. The types of articles accepted include original research articles, review articles, analytic reviews such as meta-analyses, insightful editorials, medical news, case reports, adverse drug reactions, short communications, correspondence, images in medical practice, clinical problem solving, perspectives and new drug updates. The journal publishes all research study types, from study protocols to phase I-IV trials to meta-analyses, including small or specialist studies. It is published every<strong> two months</strong> and available in print and online version. International Journal of Advances in Medicine (IJAM) complies with the uniform requirements for manuscripts submitted to biomedical journals, issued by the International Committee for Medical Journal Editors.</p> <p><strong>Issues: 6 per year</strong></p> <p><strong>Email: </strong><a href="mailto:medipeditor@gmail.com" target="_blank" rel="noopener">medipeditor@gmail.com</a>, <a href="mailto:editor@ijmedicine.com" target="_blank" rel="noopener">editor@ijmedicine.com</a></p> <p><strong>Print ISSN:</strong> 2349-3925</p> <p><strong>Online ISSN:</strong> 2349-3933</p> <p><strong>Publisher:</strong> <a href="http://www.medipacademy.com/" target="_blank" rel="noopener"><strong>Medip Academy</strong></a></p> <p><strong>DOI prefix:</strong> 10.18203</p> <p><a href="https://sci-index.org/journal/international-journal-of-advances-in-medicine" target="_blank" rel="noopener"><strong>IMPACT FACTOR: </strong></a>2.00</p> <p>Medip Academy is a member of Publishers International Linking Association, Inc. (PILA), which operates <a href="http://www.crossref.org/" target="_blank" rel="noopener">CrossRef (DOI)</a></p> <p> </p> <p><strong>Manuscript Submission</strong></p> <p>International Journal of Advances in Medicine accepts manuscript submissions through <a href="https://www.ijmedicine.com/index.php/ijam/about/submissions#onlineSubmissions" target="_blank" rel="noopener">Online Submissions</a>:</p> <p>Registration and login are required to submit manuscripts online and to check the status of current submissions.</p> <ul> <li><a href="https://www.ijmedicine.com/index.php/ijam/user/register" target="_blank" rel="noopener">Registration</a></li> <li><a href="https://www.ijmedicine.com/index.php/ijam/login" target="_blank" rel="noopener">Login</a></li> </ul> <p>Please check out the video on our YouTube Channel:</p> <p>Steps to register and submit a manuscript:<br /><a href="https://youtu.be/YHX7eUWH7bk" target="_blank" rel="noopener">https://youtu.be/YHX7eUWH7bk</a></p> <p>Problem Logging In-Clear cookies:<br /><a href="https://youtu.be/WVjZVkjB2SQ" target="_blank" rel="noopener">https://youtu.be/WVjZVkjB2SQ</a></p> <p>If you find any difficulty in online submission of your manuscript, please contact editor at <a href="mailto:medipeditor@gmail.com" target="_blank" rel="noopener">medipeditor@gmail.com</a>, <a href="mailto:editor@ijmedicine.com" target="_blank" rel="noopener">editor@ijmedicine.com</a></p> <p><strong> </strong></p> <p><strong>Abbreviation</strong></p> <p>The correct abbreviation for abstracting and indexing purposes is Int J Adv Med.</p> <p><strong> </strong></p> <p><strong>Abstracting and Indexing information</strong></p> <p>The International Journal of Advances in Medicine is indexed with</p> <ul> <li><strong><a href="https://sci-index.org/journal/international-journal-of-advances-in-medicine" target="_blank" rel="noopener">Science Citation Index</a> </strong>(Impact Factor: 2.00)</li> <li><strong><a href="https://journals.indexcopernicus.com/search/journal/issue?issueId=all&amp;journalId=31393" target="_blank" rel="noopener">Index Copernicus</a></strong><strong> </strong></li> <li><a href="https://imsear.searo.who.int/handle/123456789/156150" target="_blank" rel="noopener"><strong>Index Medicus</strong> for South-East Asia Region (WHO)</a></li> <li><strong><a title="https://www.scilit.net/wcg/container_group/7792" href="https://www.scilit.net/wcg/container_group/7792" target="_blank" rel="noopener">Scilit (MDPI)</a></strong></li> <li><a href="http://www.scopemed.org/?jid=122" target="_blank" rel="noopener">ScopeMed</a></li> <li><a href="http://www.journalindex.net/visit.php?j=9620" target="_blank" rel="noopener">Journal Index</a></li> <li><a href="http://jgateplus.com/" target="_blank" rel="noopener">J-Gate</a></li> <li><a href="http://scholar.google.co.in/" target="_blank" rel="noopener">Google Scholar</a></li> <li><a href="http://www.crossref.org/guestquery/" target="_blank" rel="noopener">CrossRef</a></li> <li><a href="http://www.directoryofscience.com/site/4548845" target="_blank" rel="noopener">Directory of Science</a></li> <li><a title="https://www.journaltocs.ac.uk/index.php?action=browse&amp;subAction=pub&amp;publisherID=3072&amp;journalID=31629&amp;pageb=1&amp;userQueryID=66977&amp;sort=&amp;local_page=1&amp;sorType=&amp;sorCol=1" href="https://www.journaltocs.ac.uk/index.php?action=browse&amp;subAction=pub&amp;publisherID=3072&amp;journalID=31629&amp;pageb=1&amp;userQueryID=66977&amp;sort=&amp;local_page=1&amp;sorType=&amp;sorCol=1" target="_blank" rel="noopener">JournalTOCs</a></li> <li><a href="http://journalseeker.researchbib.com/?action=viewJournalDetails&amp;issn=23493925&amp;uid=r4bf18" target="_blank" rel="noopener">ResearchBib</a></li> <li><a href="http://www.icmje.org/journals-following-the-icmje-recommendations/" target="_blank" rel="noopener">ICMJE</a></li> <li><a href="http://www.sherpa.ac.uk/romeo/journals.php?id=2295&amp;fIDnum=|&amp;mode=simple&amp;letter=ALL&amp;la=en" target="_blank" rel="noopener">SHERPA/RoMEO</a></li> </ul> en-US medipeditor@gmail.com (Editor) editor@ijmedicine.com (Editor) Sat, 20 Jun 2026 19:20:36 +0530 OJS 3.3.0.13 http://blogs.law.harvard.edu/tech/rss 60 Assessment of knowledge and practice of periconceptional folate intake among women attending the antenatal clinic at Bowen Teaching Hospital, Ogbomoso, Oyo State, Nigeria https://www.ijmedicine.com/index.php/ijam/article/view/4380 <p><strong>Background:</strong> Folate has an important role in reducing risk of neural tube defects in fetus and megaloblastic anemia in women of reproductive age. This study assessed the knowledge and practice of periconceptional folate intake among pregnant women attending clinic at Bowen University Teaching Hospital, Ogbomoso, Oyo State, Nigeria.</p> <p><strong>Methods:</strong> Two hundred and seventeen pregnant women were selected using simple random sampling technique. A semi-structured questionnaire was used for data collection. Descriptive and inferential statistics such as mean, frequency, percentage, standard deviation and Chi-square were used for data analysis.</p> <p><strong>Results:</strong> The study showed that most respondents were young adults aged 19–30 years (63.6%) with a mean age of 28.32±5.05 years. Majority were married (92.2%), and had at least secondary education (53.5%). Very few (7.4%) of the pregnant women had a history of stillbirth or a baby with a congenital defect, whereas 3.2% had a history of a child with a neural tube defect. Nutritional knowledge of folate intake was low (25.8%) while practice of folate intake was high (88.0%). There was no significance association (p&gt;0.05) between nutritional knowledge and practice of folate intake at (χ²=0.02, p=0.890). Key factors influencing folate rich food intake include lack of knowledge of folate rich food, poor economic status and pregnancy unplanned with mean scores (4.41), (3.22) and (3.50) respectively.</p> <p><strong>Conclusion:</strong> The study revealed that the number of respondents that had good nutritional knowledge of folate intake was low, while those that had good dietary practices were high.</p> Igbagboyemi A. Deniran, Tobi I. Akinremi, Olanike O. Balogun, Balqis R. Kareem, Maryam A. Kolapo, Sukurat O. Oke, Comfort A. Akanji Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4380 Sat, 20 Jun 2026 00:00:00 +0530 Outcomes of open radical nephrectomies in a tertiary care hospital in Nigeria: a five-year review https://www.ijmedicine.com/index.php/ijam/article/view/4431 <p><strong>Background:</strong> Open radical nephrectomy is a method of treatment of large malignant renal tumour. We aimed to review the open radical nephrectomies done in our centre with view of assessing the outcome.</p> <p><strong>Methods:</strong> Patients with suspected malignant renal tumour who had open radical nephrectomies at the Benue State University Teaching Hospital within the study period of May 2019 to April 2024 were identified and information retrieved from the records. Statistical package for the social sciences (SPSS) version 25 was used for analysis using appropriate test statistics.</p> <p><strong>Results:</strong> A total number of 23 patients had open radical nephrectomies (9 right and 14 left nephrectomies) based on clinico-radiological features of malignant renal tumours. The age range was between 9 months and 77 years. The male to female ratio was 1:1.5. The mean operating time was 2 hours 10 minutes and the average length of hospital stay was 5 days. The high-grade complication rate was 8.7%. The in-hospital mortality rate was 4.3% and the transfusion rate was 47.8%. The histology report showed 11 (47.8%) had nephroblastoma, 8 (34.8%) had renal cell carcinoma, 3 (13.0%) had oncocytoma and 1 (4.4%) had cystic nephroma.</p> <p><strong>Conclusion:</strong> Although the transfusion rate is high, open radical nephrectomy remains an option for large renal tumour as it is beneficial and gives a favourable outcome.</p> Christian A. Agbo, Edwin I. Ogwuche, Micheal E. Efu, Ushaakaa R. Swem, Sunday Urube, Stephen Atokolo, Onyejefu H. Isah, Abraham Elaigwu, Godfrey O. Odumu, Tsoho H. Gajir Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4431 Sat, 20 Jun 2026 00:00:00 +0530 Prediction of complications and death following cervical spine surgery at the National Orthopaedic Hospital, Dala, Kano, Nigeria https://www.ijmedicine.com/index.php/ijam/article/view/4450 <p><strong>Background:</strong> Cervical spine surgery is associated with significant morbidity and mortality, particularly in low-resource settings. Identifying predictors of adverse outcomes is essential for preoperative risk stratification and informed patient counselling.</p> <p><strong>Methods:</strong> A retrospective cohort study was conducted on patients who underwent cervical spine surgery for traumatic and degenerative conditions between January 2018 and December 2024 at NOH, Dala Kano. Data extracted included demographics, clinical presentation, neurological status using Frankel grading, comorbidities, injury level, surgical details and postoperative outcomes. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of complications and mortality.</p> <p><strong>Results:</strong> A total of 156 patients (124 males, 32 females) with a mean age of 44.8±14.2 years underwent cervical spine surgery. Major indication was trauma (71.8%). Overall complication rate was 31.4% and mortality rate was 9.6%. The commonest complication was respiratory tract infection (17.3%). The independent predictors of complications were: ASIA grade A injury (p&lt;0.001), high cervical injury (C1-C4) (p=0.002), associated chest injury (p=0.008) and delayed surgery &gt;7 days (p=0.012). Independent predictors of mortality were: ASIA grade A injury (p&lt;0.001), high cervical injury (p=0.001), age &gt;60 years (0.014) and presence of respiratory complications (p&lt;0.001).</p> <p><strong>Conclusions:</strong> ASIA A, high cervical level, associated chest trauma, delayed surgery and advanced age are significant predictors of adverse outcomes. These findings highlight the need for early referral, intensive perioperative respiratory support and targeted risk mitigation strategies in high-risk patients.</p> Ahidjo Abdulkadiri Kawu, Kabir Abubakar, Aminu Muhammad Nurudeen, Abdullahi Tsoho Sani, Muhammad Lawan Mamman, Muhammad Musa Chiroma, Ibrahim Attahiru Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4450 Sat, 20 Jun 2026 00:00:00 +0530 A simulation-based evaluation of synthetic control arm methodology in cardiovascular trials using propensity score matching https://www.ijmedicine.com/index.php/ijam/article/view/4462 <p><strong>Background:</strong> Conventional randomized controlled trial (RCTs) in cardiovascular medicine are expensive, ethically constrained, and logistically demanding. The synthetic control arm (SCA) methodology leverages real-world inspired simulated patient data and propensity score matching to construct an external comparator, enabling all enrolled participants to receive active treatment. Despite increasing regulatory acceptance, cardiovascular applications of this methodology remain methodologically under-characterized.</p> <p><strong>Methods:</strong> A simulation study was conducted involving 75 patients: 40 in the treatment arm receiving a combined antihypertensive and lipid-lowering agent, and 35 in the SCA control arm derived by propensity score matching on ten baseline clinical covariates. Primary endpoint was MACE at 12 months. Secondary endpoints were change in LDL cholesterol and systolic blood pressure. Statistical analyses included independent samples t-tests, Chi-squared tests, Cohen's d, odds ratios, and Kaplan-Meier survival analysis.</p> <p><strong>Results:</strong> Propensity score matching produced acceptable covariate balance across nine of ten variables (all SMD &lt;0.3), with one residual imbalance in baseline systolic BP (SMD=0.54; p=0.024). Treatment significantly reduced LDL cholesterol (−29.4±10.3 versus −5.0±5.1 mg/dl; p&lt;0.001; d=−2.94) and systolic blood pressure (−10.6±3.6 versus −3.3±3.5 mmHg; p&lt;0.001; d=−2.06). MACE occurred in 32.5% of treated versus 40.0% of SCA control patients (OR=0.72; p=0.664), non-significant owing to insufficient power at this sample size.</p> <p><strong>Conclusion:</strong> The SCA design successfully demonstrates the feasibility of SCA methodology under controlled simulation assumptions, with strong performance for surrogate endpoints but limited power for clinical endpoints in a cardiovascular simulation context, demonstrating robust detection of surrogate endpoint effects. The MACE non-significance is attributable to sample size limitations, not methodological failure. Adequate power for a 7.5 percentage-point MACE difference requires approximately 645 patients per arm. These findings provide a structured methodological framework for future SCA applications in cardiovascular pharmacoepidemiology.</p> Girik Subudhi, Shradhit Subudhi, Krish Pinto Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4462 Tue, 26 May 2026 00:00:00 +0530 Cerebral small vessel disease in an Indian cohort: magnetic resonance imaging burden, clinical profiles and risk factor associations https://www.ijmedicine.com/index.php/ijam/article/view/4448 <p><strong>Background:</strong> Cerebral small vessel disease (CSVD) is a major contributor to stroke, cognitive impairment, gait disturbances, and disability. Given its high burden and multifaceted clinical impact, CSVD has emerged as a critical public health concern. There is limited understanding of how radiological markers of CSVD correlate with clinical manifestations in Indian populations, which may differ from Western cohorts due to genetic, lifestyle, and environmental influences.</p> <p><strong>Methods:</strong> This observational, cross-sectional study included 85 adults with magnetic resonance imaging (MRI) evidence of at least one CSVD marker. Clinical assessment included cognition, gait, Parkinsonism, vascular risk factors, and stroke subtypes. MRI markers were classified per STRIVE criteria, and cumulative burden quantified using the total SVD score. Associations between radiological markers and clinical outcomes were evaluated using appropriate statistical tests.</p> <p><strong>Results:</strong> Lacunes (76.5%) and WMH (75.3%) were the most frequent markers, followed by CMB (42.4%), PVERSUS (30.6%), and RSSI (14.1%). Dementia was significantly more common in patients with lacunes (26.1% versus 5%; p=0.043) and WMH (25.6% versus 4.7%; p=0.034). CMB were strongly associated with Parkinsonism (36.1% versus 14.3%; p=0.019) and gait abnormalities (27.8% versus 10.2%; p=0.036). Higher SVD scores correlated with cerebral atrophy (68.9% versus 32.5%; p=0.001) and greater clinical impairment. Acute infarcts clustered with RSSI (50% versus 21.9%) and high SVD burden.</p> <p><strong>Conclusion:</strong> This study demonstrates substantial CSVD burden in an Indian cohort and highlights strong clinical–radiological correlations. Findings reinforce CSVD as a whole-brain, cumulative microvascular disorder with significant cognitive and motor implications.</p> Vipin Patel, Mukul Varma, Charu Gauba, Nidhi Goyal, Vaishali Kundu Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4448 Sat, 20 Jun 2026 00:00:00 +0530 Cardiometabolic index as a predictor of left ventricular remodeling post myocardial infarction https://www.ijmedicine.com/index.php/ijam/article/view/4441 <p>Myocardial Infarction has left an imprint on the heart in the form of left ventricular remodeling, which is the most important factor in the progression of heart failure and the gaining or losing of long-term cardiovascular prognosis. Traditional risk assessment has a narrow vision on metabolic factors which are most influential in the process of cardiac repair after the event. The cardiometabolic index, a composite of central adiposity along with dyslipidemia, is being recognized as a very easy and simple to use marker that reflects the metabolic stress situation. Observational studies have reported that increased cardiometabolic index is associated with unfavorable left ventricular structural changes such as concentric remodeling and hypertrophy along with decreased diastolic function indicating its use in predicting post-myocardial infarction outcomes. However, the majority of the data available so far come from studies of the general population rather than myocardial infarction-specific groups; yet the reasoning behind the mechanistic pathway is strong enough to support its presence in the post-infarction context where it provides a biologically plausible link between metabolic dysregulation and unfavorable changes in ventricle remodeling. This review presents the current evidence regarding cardiometabolic index and left ventricular remodeling, discusses its role in risk stratification and recognizes the lack of research in this regard. In order to prove cardiometabolic index as a predictor to assess its application in directing personalized interventions aimed at enhancing myocardial recovery, and to increase the associated life span of patients with heart problems, future clinical trials focusing on post-myocardial infarction patients are absolutely necessary.</p> Shiraz Rafiq, Jannat Atajanova, He Pengyi Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4441 Sat, 20 Jun 2026 00:00:00 +0530 Biosimilar insulin glargine: a solution for affordable and equitable diabetes care https://www.ijmedicine.com/index.php/ijam/article/view/4425 <p>Over past decades, insulin therapy has been a cornerstone in reshaping diabetes care from a chronically morbid disease into a manageable condition. Despite availability of multiple pharmacological therapies, diabetes patients still suffer from optimum glycaemic control especially fasting hyperglycaemia which further increase the risk of developing vascular complications. Basal insulin is a choice of medication when patients require fasting blood glucose control to achieve desired glycaemic goal. With such crucial need of basal insulin therapy for controlling fasting hyperglycaemia, it remains inaccessible for majority of patients in need. This challenge is more prevalent in low- and middle-income countries where need for insulin is rising as prevalence of diabetes increases. Biosimilar insulin has arisen as an important strategy to bridge this gap. This review addresses the outline of evolution of basal insulin therapy, especially biosimilar insulin glargine as a solution to overcome fasting hyperglycaemia. One such illustration is of biosimilar insulin glargine (BASALOG®, BIOCON) for which evidence from global clinical trials and real-world studies has demonstrated its safety, efficacy and immunogenicity comparable to the reference insulin glargine available. This has further led to the approval for biosimilar insulin glargine overseas including interchangeability designation by USFDA. Further this review underlines the Indian perspective regarding biosimilar insulin glargine affordability and adoption with emphasis on patient education, cold-chain management to increase access and real-world data generation. Collectively, biosimilar insulin glargine offers a scalable and sustainable model which has potential to expand access of basal insulin therapy to patients who are in need.</p> Harish Kumar, Jayashree Gopal, Paramesh Shamanna, Dhruvi Hasnani, Vipul Chavda, Hiren Prajapati, Hardik V. Papaiya Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4425 Sat, 20 Jun 2026 00:00:00 +0530 Preconception counseling in women with pre-existing diabetes mellitus: evidence-based strategies to improve pregnancy outcomes https://www.ijmedicine.com/index.php/ijam/article/view/4449 <p class="p1" style="margin: 0cm; text-align: justify;"><span class="s1"><span style="font-size: 10.0pt;">Pregnancy complicated by pre-existing diabetes mellitus is associated with increased maternal and fetal morbidity. Hyperglycemia during the periconceptional period significantly increases the risk of congenital malformations, spontaneous abortions, and adverse perinatal outcomes. Preconception counseling plays a vital role in optimizing metabolic control and minimizing complications before pregnancy occurs. The aim of this review is to summarize current evidence and </span></span><span style="font-size: 10.0pt;">highlight practical clinical strategies for optimizing pregnancy outcomes in women with pre-existing diabetes. A literature search was conducted using PubMed and Google Scholar for articles published between 2000 and 2024 using keywords “preconception care,” “diabetes,” and “pregnancy outcomes”. Relevant literature was identified from international clinical guidelines and peer-reviewed publications using standard database searches. <span class="s1">Optimal preconception care includes achieving strict glycemic control, screening for diabetic complications, reviewing medications, initiating folic acid supplementation, optimizing body weight, and ensuring effective contraception until glycemic targets are achieved. Multidisciplinary care involving obstetricians, endocrinologists, dieticians, and ophthalmologists is essential for comprehensive management. Evidence suggests that structured preconception programs significantly reduce congenital malformations, perinatal mortality, and maternal complications in diabetic pregnancies. Despite this, many pregnancies in women with diabetes remain unplanned, emphasizing the need for improved counseling and awareness. Early identification and management of reproductive-age women with diabetes should be incorporated into routine clinical care. Implementation of standardized preconception counseling protocols can substantially improve maternal and fetal outcomes.</span></span></p> Satya Narayan Kanchan, Hema J. Shobhane, Shivani Samaiya Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4449 Sat, 20 Jun 2026 00:00:00 +0530 The diagnostic challenge of a rare malignancy called neuroblastoma: a clinical case report https://www.ijmedicine.com/index.php/ijam/article/view/4455 <p>Neuroblastoma is a paediatric tumor that originates from neuroblasts. An interesting case report from Grodno of a child with mixed etiology showed some findings for neuroblastoma and some for Ormond's disease because the patient also has retroperitoneal fibrosis. Although both could be connected or can be separate diseases. Disease started with congenital anomaly of grade 2-3 left hydronephrosis and space occupying lesion in the retroperitoneal space (neuroblastoma). Then additional soft tissue tumor-like mass found near abdominal aorta and in the retroperitoneal space (Ormond’s disease). This could be neuroblastoma of retroperitoneal space. Although neuroblastoma can be a separate disease or it could be in association with another disease, this article discusses the abnormal clinical presentation of neuroblastoma.</p> Jenish Lakhabhai Vekariya, Olga Zenevich Valerievna, Vishrutkumar Girishbhai Sangani, Sujal Dineshbhai Solanki Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4455 Sat, 20 Jun 2026 00:00:00 +0530 Validity of rapid free T4 testing to distinguish levothyroxine non-compliance from malabsorption: a case report https://www.ijmedicine.com/index.php/ijam/article/view/4445 <p>Refractory hypothyroidism is characterised by persistently elevated thyroid-stimulating hormone (TSH) despite adequate or high-dose levothyroxine therapy. It presents a common clinical challenge, often requiring evaluation for causes such as poor adherence, drug interactions, or gastrointestinal malabsorption. Pseudomalabsorption due to inconsistent medication intake is the most frequent and reversible cause. Differentiating this from true malabsorption is crucial, as the latter may necessitate investigation for conditions like celiac disease, inflammatory bowel disease, or post-surgical states. The levothyroxine absorption test (LT4AT) is commonly used for this purpose, but conventional protocols are lengthy, costly, and inconvenient. Recently, simplified approaches using a single high oral dose with early measurement of serum free thyroxine (FT4) have been proposed. A rise in FT4 within a few hours indicates adequate intestinal absorption. We report a 54-year-old woman with refractory hypothyroidism in whom a short-duration LT4AT confirmed adequate absorption, suggesting pseudomalabsorption.</p> K. Pramila, M. Vijayalakshmi, V. Amuthavalli Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4445 Mon, 04 May 2026 00:00:00 +0530 Laparoscopic right adrenalectomy in a female with malignant hypertension secondary to pheochromocytoma: a case report https://www.ijmedicine.com/index.php/ijam/article/view/4412 <p class="abstract" style="margin-top: 12.0pt;"><span lang="EN-US">Pheochromocytomas are uncommon adrenal tumors that can present considerable clinical difficulties because of their ability for catecholamine release and hypertensive crises. We report a case of a pheochromocytoma treated effectively with laparoscopic adrenalectomy. A 36-year-old woman was presented with secondary hypertension. Preoperative IV fluids, IV PPI’s, blockade was initiated with antihypertensive drugs to optimize hemodynamic control. The patient had a laparoscopic adrenalectomy. Histopathological analysis confirmed the diagnosis of pheochromocytoma with presence of Zellballan pattern and pheochromocytoma of the adrenal gland scaled score (PASS). Complications were minimal, with low hemoglobin, and 1 unit of PRBC was transfused. Post operatively, blood pressure and electrolytes levels were normalized. Laparoscopic adrenalectomy shown to be a reliable and efficient method for treating pheochromocytoma, resulting in improved blood pressure regulation and quality of life for the patient. This case highlights the significance of a multidisciplinary strategy, encompassing preoperative medical optimization and diligent postoperative observation, in the management of pheochromocytomas, and contributes to the increasing evidence favouring laparoscopic adrenalectomy for these adrenal tumors.</span></p> B. Vijay Kumar, G. Vamshi Nandan Rao, M. Veena Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4412 Sat, 20 Jun 2026 00:00:00 +0530 The hidden airway: central airway collapse mimicking obstructive lung disease https://www.ijmedicine.com/index.php/ijam/article/view/4434 <p>Central airway collapse is an underrecognized cause of respiratory failure and is often misdiagnosed as Chronic Obstructive Pulmonary Disease or Bronchial asthma. Traditionally central airway collapse was attributed to tracheomalacia (TM), it is now increasingly differentiated from excessive dynamic airway collapse (EDAC). Excessive dynamic airway collapse (EDAC) is an underrecognized cause of chronic respiratory symptoms and is frequently presents with clinical manifestations such as cough, wheezing and exertional dyspnoea. EDAC is characterized by excessive inward bulging of the posterior membranous wall of the trachea during expiration, resulting in marked airway narrowing despite preserved tracheal cartilaginous support. Recent advances in diagnostic modalities, particularly dynamic computed tomography and fiberoptic bronchoscopy, have improved the recognition of this condition and demonstrated its occurrence in both symptomatic and asymptomatic individuals. We report the case of an 81-year-old woman who had a significant history of occupational exposure to stone dust and was an ex-smoker presented with a 10-year history of chronic cough and progressive exertional dyspnoea. Further evaluation established the diagnosis of EDAC. The patient demonstrated marked symptomatic improvement following initiation of bilevel positive airway pressure therapy along with bronchodilator treatment. This case highlights the importance of considering EDAC in patients with persistent respiratory symptoms despite standard treatment.</p> Sarika Unni, Muhammed Murshid P., Vimal Chandraghosh K. D., Shafeek M. Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4434 Sat, 20 Jun 2026 00:00:00 +0530 Unmasking lupus: acalculous cholecystitis presenting as the initial manifestation of systemic lupus erythematosus https://www.ijmedicine.com/index.php/ijam/article/view/4442 <p>Acute acalculous cholecystitis (AAC) is an uncommon cause of gallbladder inflammation, typically occurring in critically ill patients. Its presentation as the initial manifestation of systemic lupus erythematosus (SLE) is exceedingly rare. We report the case of a 30-year-old female with hypothyroidism and remote history of pleural tuberculosis, who presented with acute right upper quadrant pain, fever, photosensitive rash, oral ulcers, and generalized edema. Imaging revealed gallbladder wall thickening with pericholecystic fluid in the absence of gallstones, consistent with AAC. Serological evaluation demonstrated strongly positive ANA and anti-dsDNA antibodies with hypocomplementemia, while renal biopsy confirmed Class II mesangial proliferative lupus nephritis. Additional findings included lupus pneumonitis, pleural and peritoneal serositis, and arthralgia, establishing a diagnosis of multisystem SLE. The patient responded favourably to corticosteroids, mycophenolate mofetil, and hydroxychloroquine, with resolution of systemic features and avoidance of surgical intervention. This case highlights AAC as a rare heralding manifestation of SLE and underscores the importance of considering autoimmune etiologies in atypical AAC presentations. Early recognition and prompt immunosuppressive therapy are crucial to prevent unnecessary cholecystectomy and irreversible organ damage.</p> Parul Sharma, Ramesh Aggarwal, Soumya Gupta, Dheeraj Kumar, Atul Goel, Vineeta Batra, Rosmy Jose, Prasanta Deka, Shivraj Meena Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4442 Sat, 20 Jun 2026 00:00:00 +0530 Ayurvedic intervention in ovarian factor infertility: a clinical case study https://www.ijmedicine.com/index.php/ijam/article/view/4446 <p>Most crucial stress for women in now days are having infertility issue. Successful healthy conception requires proper structure and function of entire reproductive system. Anti-mullerian hormone is an ovarian reserve marker that effects in ovulation and endometrium thickness. Low anti-mullerian hormone has become first choice for IVF centre. There is the great scope of Ayurveda research to find out appropriate and effective solution for this problem. Considering all these points the present study was planned according to Ayurvedic principles. A 29 years female presented with a 4-year history of inability to conceive and was diagnosed with poor ovarian reserve and anovulation based on her reports. Patient was treated with Virechana, Madhutailik Basti, Mustadi Yapana Basti, Uttarbasti and Shamana Aushadha. There was an improvement in endometrium thickness, ovulation occurred and the patient subsequently conceived and delivered a full term healthy male child. The administered therapy helped correct Dosha vitiation, which in turn promoted fertility restoration. The treatment led to ovarian function, restoration of ovulation and successful conception culminating in a full-term normal delivery.</p> Matangee Pandya, Jasmina Acharya Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4446 Sat, 20 Jun 2026 00:00:00 +0530 Effective management of indralupta (alopecia areata) through Ayurveda: a case study https://www.ijmedicine.com/index.php/ijam/article/view/4467 <p>Alopecia areata (AA) is an autoimmune condition that causes round bald patches, usually on areas of the body where hair normally grows most commonly on the scalp. In Ayurveda, this condition is compared to indralupta. According to ayurvedic understanding, indralupta is caused by an imbalance of the three doshas (Vata, Pitta and Kapha) along with Rakta (blood). This is a case study of 28 years old male patient came to OPD having complaints of bald patches over scalp region for 6 months. Patient was diagnosed with indralupta and managed by Samana therapy. Treatment for 4 months along with the diet regimen mentioned in ayurvedic text was followed. The patient got speedy recovery with remarkable regrowth of scalp hair within 4 months of treatment. Classical indralupta chikitsa mentioned in ayurvedic classics is effective in the management of alopecia areata.</p> Varsha V., Sisir Kumar Mandal Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4467 Sat, 20 Jun 2026 00:00:00 +0530 Late cutaneous form of porphyria cutanea tarda in a 26-year-old man: a clinical case report https://www.ijmedicine.com/index.php/ijam/article/view/4456 <p>Porphyria cutanea tarda (PCT) is a rare form of enzymatic disorder of heme-biosynthesis pathway. Due to a defect of enzyme uroporphyrinogen decarboxylase (UROD) this disease occurs. Porphyria cutanea tarda can be sporadic and can be familial. Here, we are presenting a late cutaneous form of porphyria cutanea tarda in a 26-year-old male patient without any known triggers. The patient was diagnosed by genetic and laboratory testing and showed typical appearance of PCT. All the details of PCT from presentation of symptoms, complications, involvement of organs and diagnosis is discussed in this article. Furthermore, this article provides thorough discussion about PCT.</p> Jenish Lakhabhai Vekariya, Alexandra L. Potapchik, Yana Igorevna Kalninya, Ketan Nandkishor Patil Copyright (c) 2026 International Journal of Advances in Medicine https://www.ijmedicine.com/index.php/ijam/article/view/4456 Sat, 20 Jun 2026 00:00:00 +0530